We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry's therapies, which includes royalti... Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry's therapies, which includes royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Johnson & Johnson's Tremfya, Gilead's Trodelvy, Merck's Januvia, Novartis' Promacta, Vertex's Kalydeco, Orkambi, Symdeko and Trikafta, and ten development-stage product candidates. Show more
NEW YORK and COPENHAGEN, Denmark, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Ascendis Pharma A/S (Nasdaq: ASND) today announced that Royalty Pharma and Ascendis...
COPENHAGEN, Denmark and NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) and Royalty Pharma plc (Nasdaq: RPRX) today announced that Ascendis Pharma Bone Diseases...
NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at Morgan Stanley’s 22nd Annual Health Care Conference...
Portfolio Receipts growth of 12% to $608 million; Royalty Receipts growth of 11%Net cash provided by operating activities of $658 millionRaising full year 2024 guidance: Portfolio Receipts...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.17 | 0.606276747504 | 28.04 | 28.48 | 27.48 | 1956146 | 27.86717293 | CS |
4 | 0.82 | 2.99379335524 | 27.39 | 29.37 | 27.3 | 2320686 | 28.26371365 | CS |
12 | 1.41 | 5.26119402985 | 26.8 | 29.37 | 25.2 | 2653260 | 27.45752214 | CS |
26 | -1.93 | -6.40345056403 | 30.14 | 30.8 | 25.2 | 2639241 | 27.77203353 | CS |
52 | 0.16 | 0.570409982175 | 28.05 | 31.655 | 25.2 | 2594004 | 28.06360561 | CS |
156 | -9.79 | -25.7631578947 | 38 | 44.75 | 25.2 | 2161436 | 34.05487535 | CS |
260 | -17.69 | -38.5403050109 | 45.9 | 57.5 | 25.2 | 2186492 | 37.05419207 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions